Sotera Health Company (SHC) Institutional Ownership & Insider Trading

319 institutions reported holding Sotera Health Company shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SHCSotera Health CompanyFollow SHC — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 5.2B
P/E TTM: 31.8
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

319 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +5.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	319	293	+5.9%	159	45	60	27
Mar 26	294	274	+3.2%	139	41	57	33
Dec 25	281	267	+0.2%	138	63	33	26
Sep 25	238	265	-2.5%	107	37	47	23
Jun 25	223	273	+3.1%	90	42	47	22
Mar 25	205	270	+2.4%	53	20	69	30
Dec 24	215	265	-1.6%	78	25	51	26
Sep 24	206	265	-0.1%	98	24	41	25

Sotera Health Company — questions

Who owns Sotera Health Company stock?: 319 institutions reported Sotera Health Company shares in 13F filings for the quarter ended 2026-06-30. The largest: Sessa Capital IM, L.P. (9.5%), Darsana Capital Partners LP (9.5%), BlackRock, Inc. (8.5%).
Are Sotera Health Company insiders buying or selling?: 18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Sotera Health Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.